# Brain Case

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brain-case

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.braincase.cn
- Latest round: Angel (Sep 2, 2022)
- Investors on record: 2

## About

Established in 2020 and based in Shenzhen, China, Brain Case operates as a tool virus vector and translational medicine research provider. The company was established by brain science research team of Chinese academy of sciences. The core research team has more than 40 employees. It has more than 1800 viral vectors.

The business of the company includes gene therapy, mutual research and development. The company's services include sparse labeling, detection of VSV interferon activity, transformation of oncolytic virus vectors, construction of stable cell lines and ion channel screening. Its products include adeno-associated virus (AAV), including photogenetic activation, photogenetic inhibition, chemical inheritance and fluorescent protein. AAV can apply in cardiac targeting, hepatic targeting, pancreatic targeting and renal targeting. The company will settle in brain trauma center.

## Funding rounds

- Angel, Sep 2, 2022 — Landmark Capital, Zhongke Angel Fund

## Investors

- Landmark Capital (https://capitalatlas.ai/funds/landmark-capital) — Angel
- Zhongke Angel Fund (https://capitalatlas.ai/funds/zhongke-angel-fund) — Angel